Hints and tips:
...Follow Robert on Twitter @robertshrimsley and email him at robert.shrimsley@ft.com Follow @FTMag on Twitter to find out about our latest stories first...
...We have a blow-by-blow explanation of how this “short squeeze” has developed and Robert Armstrong has answers to the key questions, such as whether this will end badly. “Definitely,” he says....
...The global equity strategy team at Citi, led by Robert Buckland, say stocks around the world may well be stuck over the next 12 months....
...But sales of the Ariens Ikon XD, featuring 20-inch tyres, a V-twin Kawasaki engine and ergonomic plush seat, have surged in the US during the pandemic....
...“I would say that, as a team, we've pretty well discounted a uniform V-shaped recovery. The question is, is it U-shaped, is it W-shaped or parts of it L-shaped?”...
...Deutsche Bank’s satellite-powered shipping tracker indicates that Chinese economic activity has now stopped contracting, and some economists are predicting a V-shaped recovery....
...Xerox wants to give HP’s board its walking papers We’re all guilty of overusing the David v Goliath trope but in the case of Xerox and HP, it really does apply....
...Ms Schoen said she believed it was unlikely that the court would overturn Roe v Wade....
...DD’s Indap v NYU’s Damodaran: Is stock compensation good or bad?...
...The 1984 case, formally known as “Chevron USA Inc v Natural Resources Defense Council Inc” formalised the legal doctrine that requires judges to defer to administrative agencies’ interpretation of federal...
...Get in touch with us: Due.Diligence@FT.com Altice and Goldman A scoop from the FT’s Robert Smith and Harriet Agnew on Monday — about Goldman Sachs’ efforts to sell on debt exposure to Altice — sent some...
...A 34oz bottle of P&G’s Pantene Pro-V Shampoo & Conditioner was listed by 10 different sellers — nine of them third parties — on the shopping site....
...In an interview last year, Robert Caro, the acclaimed biographer of New York city planner Robert Moses, shared a simple insight that explained how an architect “can shape a metropolis for generations”:...
...A version of this article was first published by the Nikkei Asian Review on April 20, 2018. ©2018 Nikkei Inc. All rights reserved....
...Tuesday’s judgement (case number 15-1189, Impression Products, Inc. v....
...“All the broad themes of the Trump rally — deregulation; infrastructure; tax reform; domestic v international — seem almost tailor-made to trigger a cable rally,” wrote analysts at Moffett Nathanson....
...Aerojet said the AR1 would be ready to fly on Atlas V in 2020 and on Vulcan by 2021, only just behind the 2019 finish date that Blue Origin is targeting....
...(CPI) Number of the day 73% v 28%The proportion of remaining delegates that Sanders would need to win in order to secure the nomination, compared to what Clinton needs....
...Aerojet’s offer underlines the company’s desire to supply the engine for the new Vulcan rocket that ULA is developing to replace its Atlas V, which is powered by Russia-built engines that congress has said...
...Among their investors are Time Warner, 21st Century Fox, Google Capital, the National Hockey League and NFL owners Robert Kraft and Jerry Jones....
.... …………………………………………………………………………………………………………… Ben Hall, world news editor, picks: • Isis Inc: how oil fuels jihadi terrorists by Erika Solomon, Guy Chazan and Sam Jones• Why China’s ‘migrant miracle’ is...
...The engines — powered by methane, a new propellant for US-built engines — will initially power a similar rocket to the Atlas V that ULA powers with Russian-built RD180 engines....
...Freemium v paid: Streaming competition swells YouTube is one of several Spotify competitors bringing streaming services to the market this year....
...“We’re here to disrupt and shatter the status quo and dispel preconceived notions,” Johan de Nysschen, Cadillac’s chief executive, said at the unveiling of the new Cadillac CTS-V, a performance version of...
...of the US in a $900m deal that gives the company its first future blockbuster: Adderall, an amphetamine-based drug for attention deficit hyperactivity disorder (ADHD). 2000: The $4bn takeover of BioChem...
International Edition